MediWound Competitors and Similar CompaniesClear all
MediWound's competitors and similar companies include Aatru Medical, Immatics, Alexion Pharmaceuticals and Ansun BioPharma.
 MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Ansun BioPharma Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses. | ||
Founding Date | Founding Date 2001 | Founding Date 2015 | Founding Date N/A | Founding Date 1992 | Founding Date 2003 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations Cleveland, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ |
Employees | Employees 111 | Employees 6 | Employees 29723% increase | Employees 10,6006% increase | Employees 22 |
Valuation ($) | Valuation ($) 196.3 m | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 40.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $17m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) N/A |
Cost of goods | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $553.5m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit $4.1m (FY, 2025) | Gross profit N/A | Gross profit €53m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit N/A |
Net income | Net income ($23.9m) (FY, 2025) | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income $603.4m (FY, 2020) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 420k | Total funding raised $ 267.3m | Total funding raised N/A | Total funding raised $ 183.9m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyAlexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyAnsun BioPharma
HQ
San Diego, US
Employees
22
Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses.
View company